Relmada Therapeutics Inc.

AI Score

0

Unlock

0.26
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
0.24
-5.22%
After-hours: Mar 03, 2025, 06:03 PM EST

Relmada Therapeutics Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 2. The median target predicts an increase of 284.62% from the current stock price of 0.26.

Target Low Average Median High
Price $1 $1.33 $1 $2
Change 284.62% 411.54% 284.62% 669.23%

AI Analyst Report

According to 4 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Jun 24Sep 24Dec 24
Strong Buy 010
Buy 000
Hold 002
Sell 100
Strong Sell 000
Total 1 1 2

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
2.46M
from 0
Increased by -%
EPS This Year
-2.74
from -3.28
Increased by 16.5%
EPS Next Year
-1.15
from -2.74
Increased by 58.0%